The University of New Mexico Addiction and Substance Abuse Programs (ASAP) at the Health Sciences Center is conducting a study to see which schedule of treatment is better for young adults addicted to heroin.

ASAP wants to see if patients receiving Bup/Nal (buprenorphine/ naxolone) combined with psychosocial treatments have fewer opiod positive urine tests at a three-month point than those with the usual treatment, which is just detoxification plus psychosocial treatment.

Secondary objectives are to determine if Bup/Nal is associated with longer time to drop out from psychosocial treatment less opiod use by self-report, less HIV risk, less non-opiod substance use, better psychosocial functioning, less delinquency, an fewer total problem behaviors during the first 12-week treatment period. The study will also determine if the improved outcomes in the Bup/Nal condition are maintained at three, six, nine and 12-month follow-ups.

Bup/Nal has recently been approved by the FDA for treatment of addiction to heroin and other narcotics.

The 14 to 21 year old participants in the study will receive free counseling, medication, study-related medical care (such as HIV, pregnancy, urine tests) and will be paid for completion of research interviews and questionnaires. There is no placebo group, which means all participants will receive active medication.

The study will be conducted at UNM ASAP 2450 Alamo SE (formerly CASAA, 2350 Alamo) and at Ayudantes in Espanola.  For more information call 505-925-2400 or 505-438-0035.


Contact: Jennifer Riordan, 272-3322